Appraisal of Investments in Health Care

Course Description

The course studies how the healthcare related industries are affected by the dynamic shifts in the market. The traditional paths to innovation are no longer suitable. The growing interest in biologic drugs, the shift from blockbusters to niche medicines, and the differing needs of emerging markets all have affected the cost structure and profitability of drug manufacturers, which is in turn affecting R&D needs and capabilities. Successful companies have developed innovation networks including varying external groups to support the discovery, development, and commercialization of new therapies.